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Scienze Biologiche, Universita` degli Studi di Napoli Federico II, Naples, ItalyABSTRACT Neurotrophins (NTs) represent a family of proteins that play an important role in the survival, development,
and function of neurons. Extensive efforts are currently being made to develop small molecules endowed with agonist or
antagonist NT activity. The structurally versatile N-termini of these proteins are considered regions of interest for the design
of new molecules. By combining experimental and computational approaches, we analyzed the intrinsic conformational
preferences of the N-termini of two of the most important NTs: NGF (NGF-Nter) and NT4 (NT4-Nter). Circular dichroism spectra
clearly indicate that both peptides show a preference for random coil states. Because this finding does not preclude the
possibility that structured forms may occur in solution as minor conformational states, we performed molecular-dynamics
simulations to gain insights into the structural features of populated species. In line with the circular dichroism analysis, the
simulations show a preference for unstructured states for both peptides. However, the simulations also show that for NT4-Nter,
and to a lesser extent for NGF-Nter, helical conformations, which are required for binding to the Trk receptor, are present in the
repertoire of structures that are intrinsically accessible to these peptides. Accordingly, molecular recognition of NTs by the Trk
receptor is accomplished by the general mechanism known as population shift. These findings provide a structural rationale
for the observed activity of synthetic peptides based on these NT regions. They also suggest strategies for the development
of biologically active peptide-based compounds.INTRODUCTIONNeurotrophins (NTs) play a crucial role in the differentia-
tion, survival, and maintenance of nerve cells (1). This
protein family includes nerve growth factor (NGF), brain-
derived neurotrophic factor (BDNF), neurotrophin 3 (NT3),
neurotrophin 4/5 (NT4), and neurotrophin 6 (NT6) (2,3).
Although the fine details of their function have yet to be
fully elucidated, it is generally accepted that these pro-
teins exert their effects by interacting with two types of
transmembrane receptors belonging to either the tyrosine
kinase (Trk) or tumor necrosis factor (p75) families. The
Trk receptors (TrkA, TrkB, and TrkC) show specificity in
their preference for NT binding, whereas the p75 receptor
interacts with all NTs, albeit with slightly different binding
affinities.
The involvement of NTs in biological processes linked
to the emergence of severe and widespread pathologies
has suggested their use as promising therapeutic agents.
Although several independent investigations have indeed
provided support for this idea (4,5), the use of NTs as drugs
has been hampered by their poor pharmaceutical properties
(6). Therefore, particular attention is being given to the
development of mimetics endowed with NT-like activities.
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agonists or competitive antagonists (7–13), some of which
have also proven to be active in vivo. Indeed, experiments
conducted with synthetic NGF agonists have shown im-
provements in memory and cholinergic phenotype in cogni-
tively impaired aged rats (14), and the ability to restore
neuronal function and reduce reactive gliosis in a rat model
of chronic constriction injury (7).
The rational design of effective NT mimetics relies
strongly on detailed information about their interaction
with receptors. Extensive crystallographic investigations
have provided a detailed picture of NTs structures in their
unliganded states and in complex with receptors (Trk and
p75) (15–24). Comparative analyses of different crystallo-
graphic structures have unveiled an intriguing dynamic
behavior of NT N-terminal regions. There is clear evidence
that these fragments, which are likely unfolded in unli-
ganded NTs, become ordered only upon binding to Trk
receptors (24). Moreover, N-terminal regions of different
NTs exhibit different structural properties. Indeed, the
N-terminus of NGF mediates the interactions with TrkA
by assuming an a-helical structure (24). On the other
hand, the N-terminal region of NT4 forms a 3–10 helix
upon binding to TrkB (20).
To date, computational studies aimed at unveiling the
dynamic properties of NTs and their receptors remain
rather limited (25,26). Previous molecular-dynamics (MD)
simulations focused on analyzing the dynamic properties
of the complex between NGF and TrkA, as well as thedoi: 10.1016/j.bpj.2010.07.054
2274 Stanzione et al.energetic factors involved in the NGF N-terminal recogni-
tion by the TrkA receptor (25,26).
Because the N-terminal regions of NTs are considered
hot spots for the design of NT agonist/antagonists (27), we
performed a combined circular dichroism (CD) and MD
investigation aimed at identifying the intrinsic conforma-
tional preferences of the N-terminal regions of both NGF
and NT4. The results of our investigation provide insights
into the recognition process between NTs and Trk receptors,
and guidelines for the design of new NT mimetics.MATERIALS AND METHODS
Peptide synthesis
Peptides corresponding to the N-terminal region of NT4 and NGF (see
Table 1 for the sequence) were purchased from Inbios Laboratories
(Pozzuoli, Italy) and used without further purification.CD spectroscopy
CD spectra on the peptides were recorded with a Jasco J-810 spectropo-
larimeter equipped with a Peltier temperature control system (model
PTC-423-S). Molar ellipticity per mean residue, [q] in deg cm2  dmol1,
was calculated from the equation [q] ¼ [q]obs  mrw  (10  l  C)1,
where [q]obs is the ellipticity measured in degrees, mrw is the mean residue
molecular mass,C is the protein concentration in g l1, and l is the optical
path length of the cell in centimeters. Far-UV measurements (190–230 nm)
were carried out with a 0.1 cm optical path length cell. The concentration of
NGF-Nter and NT4-Nter was 0.030 and 0.027 mM, respectively. The CD
spectra reported in Fig. 1 were signal-averaged over three scans. Other
parameters of the CD spectra registration are identical to those adopted
in previous studies (28).FIGURE 1 Far-UV CD spectra of (A) NT4-Nter and (B) NGF-Nter.
MD simulations
The MD simulations were conducted on the N-terminal fragments (residues
1–16) of NGF and NT4 (Table 1). To avoid any bias in the MD analysis, the
simulations were performed by assuming an extended conformation for
both peptides. To emulate the state of the peptides in the corresponding
proteins, their N- and C-termini were kept charged and uncharged, respec-
tively. Because the overall charge of NT4-Nter was þ1, a Cl ion was
added to neutralize the simulated system. The AMBER03 force field (29)
and the Tip3p water model implemented in the program GROMACS (30)
were used in the simulations. For both systems, to relax bond geometries,
the potential energy of the system (peptides and water) was minimized
by using the steepest-descent method until convergence was reached. The
solvent was then relaxed by 50 ps of MD at 300 K, restraining protein
atomic positions with a harmonic potential. The system temperature was
brought to 300 K in a stepwise manner: 30 ps MD runs were carried out
at 50, 100, 150, 200, 250, and 300 K. We checked to ensure that in each
step of the heating of the different systems, the potential energy reached
a stable value. The timescale of the individual simulations is reported inTABLE 1 Sequences of the peptides characterized in this
study
NT4-Nter 1GVSETAPASRRGELAV16
NGF-Nter 1SSSHPIFHRGEFSVCD16
The region highlighted in gray represents the a-helical region detected
in the structure of the complex NGF-TrkA (PDB code: 1WWW), and the
3–10 helix found in the complex NT4-TrkB (PDB code: 1HCF).
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Bond lengths were constrained by the LINCS algorithm. The electrostatic
interactions were calculated using the particle mesh Ewald algorithm
with a cutoff of 0.9 nm. The cutoff radius for the Lennard-Jones interactions
was set to 0.9 nm. A dielectric constant of 1, and a time step of 2 fs were
used. We used the NVT ensemble in all simulations. The temperature was
maintained constant using the Berendsen thermostat with a time constant of
0.1 ps. Trajectory structures were analyzed by using GROMACS (30) and
VMD (31) routines.RESULTS AND DISCUSSION
To characterize the intrinsic conformational preferences of
the N-terminal regions of both NT4 and NGF, we adopted
an integrated experimental (CD) and computational (MD)
approach.CD spectroscopy
To avoid any bias caused by chain termination, the length
of the peptides corresponding to the N-terminus of the
two NTs considered here was larger than the regions
TABLE 2 Summary of the simulations performed in this study
Model
No. atom
peptide/ No.
atom water/Cl
Box
dimension (A˚3)
Simulation
time (ns) T(K)
NT4-Nterm 227/23991/1 62  62  62 200 300
NGF-Nter 240/23952 62  62  62 200 300
QK-peptide 280/32103/2 69  69  69 200 300
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shown in Table 1, the first 16 residues of the two proteins
were considered. The far-UV spectrum of NT4-Nter mea-
sured at room temperature shows a minimum at ~200 nm
(Fig. 1 A). A similar trend is exhibited by the spectrum of
NGF-Nter (Fig. 1 B). Although, given the intrinsic limita-
tions of the technique, these analyses do not preclude the
possibility that structured forms of these peptides occur in
solution as minor conformational states, these spectra
clearly indicate that both peptides show a preference for
random coil states.MD simulations
To investigate the structural ensemble of these peptide at the
atomic level and to verify the occurrence of low-populated
structured states, we performed rather long MD simulations
(200 ns) on both NT4-Nter and NGF-Nter by using the
AMBER03 (29) force field, which has been proven to be
well suited for the analysis of the peptide structured states
(32), implemented in the program GROMACS (30).
We also checked that a test simulation carried out on the
a-helical QK-peptide (sequence Ac-KLTWQELYQLKY
KGI-NH2) (33) using the potential, parameters, and equili-
bration protocol employed in NT4-Nter and NGF-Nter
MD analyses was able to reproduce the expected conforma-
tional behavior of QK-peptide (see Fig. S1 in the Supporting
Material).NT4 N-terminal peptide
To minimize the bias caused by specific structural features
of the starting model of the peptide used in the MD simula-
tions, it was built in an extended conformation (Fig. 2 A).
The initial stages of the simulation were characterized
by a collapse of the extended conformer. These transitions
led to the formation of transient turns and bends within
the peptide. The analysis of the MD structures was con-
ducted by excluding the first 50 ns of the trajectory, which
could have been influenced by the starting state. As shown
in Fig. 2, the NT4-Nter displays a remarkable dynamical
behavior. The ensemble of the structures detected in the
MD trajectory is highly variable. In line with the results of
the CD analysis, most of the NT4-Nter structures do not
exhibit regular secondary structure elements. Nevertheless,
in a small but significant (~20%) fraction of conformers,a 3–10 helix motif is detected in the central region of the
peptide. As shown in Fig. 2, B–E, residues spanning from
8 to 10 form a short 3–10 helix that folds and unwinds
many times in the simulation. A deeper inspection of the
trajectory shows that the helical structure is more persistent
in the 55–70 and 150–170 ns intervals (Fig. 2, D and E).
Because this secondary structure motif relies on the forma-
tion of backbone hydrogen bonds, we analyzed the evolu-
tion of distances between potentially interacting atoms.
We detected the formation of transient hydrogen bonds
between 1), the O atom of Pro7 and the N atom of Arg10;
and 2), the O atom of Ala8 and the N atom of Arg11
(Fig. 3 A). Although these atoms were quite distant in the
starting extended NT4-Nter model (~15 A˚), they frequently
came closer than 3.0 A˚. It is worth noting that the interaction
between O Pro7 and N Arg10 is more preserved than the one
between OAla8 and NArg11. Of note, these hydrogen bonds
are also detected in the structure of NT4 in its complex with
TrkB (20). Although the NT4-Nter region contains charged
groups, its helical state is not stabilized by specific electro-
static interactions. The structural similarity of the 3–10 con-
formers identified in the MD ensemble with the structure of
the NT4 N-terminus in the complex with TrkB is of partic-
ular interest. As shown in Fig. 4, a representative example of
the 3–10 conformers detected in the simulation perfectly fits
the structure of the protein in the complex. This finding
suggests that although it is highly flexible, the conformation
needed for the binding to the receptor is present in the reper-
toire of structures intrinsically accessible to NT4-Nter.MD simulation on the NGF N-terminal peptide
The overall procedure adopted for investigating the intrinsic
conformational preferences of NT4-Nter was extended to
NGF-Nter, the N-terminal region of NGF (see Table 1 for
the sequence). As found for NT4-Nter, the 200 ns MD simu-
lation on NGF-Nter clearly shows that this peptide is intrin-
sically highly flexible (Fig. 2, F–I). In line with the CD
experiments, most of the NGF-Nter conformations do not
present a regular secondary structure. A helical structure
is detected for a limited fraction of conformers present in
the ensemble. In contrast to what is observed for NT4-
Nter, the helical structure is detected for a NGF-Nter region
(residues 10–12) that is buried in the native protein. Only an
almost negligible portion (~1%) of NGF-Nter simulation
structures presents a helical structure in the region that the
NGF N-terminus uses for TrkA binding (residues 6–8).
The analysis of the distances between NGF-Nter atoms
that are hydrogen-bonded in the NGF-TrkA complex shows
that these atoms infrequently come close in the simulation
(Fig. 3 B). This is particularly evident for the hydrogen-
bonding partners O Ile6-N Gly10, whose distance is
rarely less than 6 A˚ in the simulation. In conclusion, the
MD simulation carried out on NGF-Nter is in line with
the CD results. It also highlights significant differencesBiophysical Journal 99(7) 2273–2278
FIGURE 2 MD of NT4 N-terminal peptide (A–E) and NGF N-terminal peptide (F–I): (A) starting model, (B) percentage of time that each residue spent in
helical conformation on the simulation timescale (50–200 ns), (C) secondary structure formation along the trajectory, (D and E) snapshots of the secondary
structure formation of specific regions of the trajectory, (F) starting model, (G) percentage of time that each residue spent in helical conformation on the
simulation timescale (50–200 ns), (H) secondary structure formation along the trajectory, and (I) a representative helical structure selected from the trajectory.
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that of NT4-Nter.Implications for the molecular recognition
of NTs by receptors
Because previous structural studies have revealed that the
N-terminal regions of NT4 and NGF are not involved in
specific interactions with the rest of the protein (20,24),
the findings reported above, generated from an analysis of
the isolated peptides, are also significant in the framework
of the entire proteins. The observation that both peptides
display a variety of different states is in line with crystallo-
graphic data. Indeed, these previous studies showed that
they assume different conformations in the unliganded
NTs, or when the NTs are in complex either with Trk or
with p75 receptors. This conformational versatility is an
important structural feature that allows these proteins to
interact with diversified receptors. The data presentedBiophysical Journal 99(7) 2273–2278here indicate that for NT4-Nter, and to a lesser extent for
NGF-Nter, the conformation of the peptide that is prone to
Trk binding is already present among the energetically
accessible states. Considered in a more general context,
these findings show that Trk recognition by NTs is accom-
plished by the general mechanism known as population shift
(34,35). In other words, rather than remodeling the structure
of the N-terminal region of the NTs (induced fit), the
receptor selects states that are already populated.
The MD simulations reported here also suggest that the
N-termini of the two NTs have a distinct conformational
behavior. This is not surprising, as the sequences of the
N-termini of these NTs do not display any significant simi-
larity (Table 1) despite an overall 47% sequence identity for
the rest of the proteins. The lower tendency of NGF-Nter to
intrinsically assume the helical state that is essential for
binding to TrkA may be related to the presence of an Ile
residue in its central region (position 6). Indeed, it is well
established that Ile residues have a poor helical propensity.
FIGURE 4 Representative example of a 3–10 helical model of NT4-Nter
derived from the simulation superimposed on the N-terminal region of the
NT4 (light gray) in the NT4-TrkB complex. The TrkB receptor is colored in
dark gray. The model of the complex was generated from the coordinates of
PDB entry 1HCF.
FIGURE 3 Evolution of the distances between atoms involved in the
hydrogen bonds that stabilize (A) the 3–10 helix in the complex NT4-TrkB:
O Pro7-N Arg10 (black) and O Ala8-N Arg11 (gray), and (B) the a-helix in
the complex NGF-TrkA: O Pro5-N Arg9 (black) and O Ile6-N Gly10 (gray).
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shows that this residue makes extensive hydrophobic
contacts with the receptor. Evidently, these interactions
compensate for the lower helical preorganization of the
peptide due to the presence of this residue. Of note, in 48
NGF sequences isolated from different organisms reported
in the Swiss-Prot database (http://www.expasy.ch/sprot),
this residue is either conserved or replaced with a valine.
Since valine has a similar low propensity for helical struc-
tures and a similar hydrophobic side chain, the consider-
ations reported above hold for all known NGF variants.
It is also important to note that a secondary-structure
prediction analysis, using the PSIPRED Protein Structure
Prediction Server (http://www.psipred.net/psiform.html),
of the peptide fragments examined here indicates a general
agreement with the MD simulations. Indeed, this analysis
suggests that NT4-Nter has a limited intrinsic tendency to
form helical structure in region 8–12 (confidence score: 3
out of 9), whereas the highly helical QK-peptide shows a
confidence score of 8 out of 9 in its N-terminal region, in
line with the MD results. On the other hand, according to
the prediction, the peptide NGF-Nter does not display any
significant tendency to form helical structure. The prefer-ence of NT N-termini for unstructured states also provides
insights into the ineffectiveness of peptides designed on
the sequence of NGF N-terminus as NTs mimetics. In
fact, it has been shown that when the sequence of the
NGF N-terminus is conjugated to sequences of loops of
the protein, negligible effects in their agonist activity are
observed (7). The limited population of the helical state,
which is required for binding, straightforwardly explains
these observations. This consideration also prompts feasible
strategies for the design of effective NT agonist/antagonists.
Indeed, variants of this peptide with an increased helical
propensity likely better mimic the NT functions. Several
previous studies on other systems conducted using this
strategy provide indirect support for the proposed approach
(33,36,37).CONCLUSIONS
The combined experimental and theoretical approach here
reported provides a detailed picture of the NT N-terminal
regions, which are considered hot spots in the molecular
recognition between NT and their Trk receptors. Previous
MD analyses focused on the evolution of the determinants
of NGF-Nter recognition in its helical state by TrkA
(25,26). Here, we complement those studies by providing
information on the intrinsic conformational properties of
NT N-terminal regions. Our MD simulations, which are
compatible with the experimental CD analysis, give insights
into the structural features of low-populated species. Not
only do our findings provide a structural explanation for
the observed activity of synthetic peptides containing these
NT regions, they also suggest strategies for the development
of effective peptide-based, biologically active molecules. In
particular, the design of peptide mimetics of these regions,
containing amino acids endowed with enhanced preferencesBiophysical Journal 99(7) 2273–2278
2278 Stanzione et al.for these structural motifs, is likely to yield high-affinity
compounds for these receptors. Depending on their mono-
meric or dimeric state, these peptides may act as NT antago-
nists or agonists. Moreover, these peptides may be used to
create conjugates with bioactive oligonucleotides for the
selective targeting of cells overexpressing Trk receptors (38).SUPPORTING MATERIAL
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